多发性骨髓瘤的基因组分类和个体化预后
Francesco Maura1, Arjun Raj Rajanna1, Bachisio Ziccheddu1
1Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
概括
这项研究开发了一种新的模型,通过整合临床,基因组和治疗数据,预测新诊断的多发性骨髓瘤 (NDMM) 的个性化风险. IRMMa模型为个性化治疗决策提供了卓越的准确性.
科学领域:
- 血液学 血液学 血液学
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 的结果是高度可变的.
- 新诊断的MM (NDMM) 患者表现出不同的生存率,需要更好的风险分层.
研究的目的:
- 为NDMM开发一个个性化的风险预测模型.
- 整合临床,基因组和治疗数据,以提高预后准确度.
- 在NDMM中指导个性化治疗策略.
主要方法:
- 组建了一个由1933名NDMM患者组成的队列,提供了全面的数据.
- 利用基因组驱动器来定义12个分子组.
- 开发了一个多状态模型,包括临床,基因组和治疗变量,包括高剂量的梅尔法兰与自身干细胞移植 (HDM-ASCT).
主要成果:
- 多发性骨髓瘤 (IRMMa) 模型中的个性化风险实现了0.726的整体存活率 (OS) 的c指数,超过了现有的模型 (ISS,修订-ISS,R2-ISS).
- 关键预测因素包括20个基因组特征,如1q21增益/增强,del1p,TP53损失,NSD2转位和APOBEC/复制号签名.
- 在GMMG-HD6试验中验证了IRMMa的准确性,证明了卓越的预测能力,并确定了基因组之间的治疗差异.
结论:
- 通过整合各种患者数据,开发了第一个针对NDMM的个性化风险预测模型.
- IRMMa模型可以为NDMM患者做出个性化治疗决策.
- 这种方法增强了基于个体风险概况和基因组特征的治疗量身定制.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K